Gene-editing by CRISPR–Cas9 in combination with anthracycline therapy <i>via</i> tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppression

Chen-Shen Wang(National Yang Ming Chiao Tung University), Yu‐Li Lo(Institute of Pharmacology)
Nanoscale Horizons
January 1, 2021
10.1039/d1nh00254f
Cited by 57

Related Papers

Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides
|Journal of Nanobiotechnology|2019|60
Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells
|PLoS ONE|2017|47
Galectin-3 Silencing Inhibits Epirubicin-Induced ATP Binding Cassette Transporters and Activates the Mitochondrial Apoptosis Pathway via β-Catenin/GSK-3β Modulation in Colorectal Carcinoma
|PLoS ONE|2013|43
Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2&amp;ndash;3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells
|International Journal of Nanomedicine|2016|40
Mitochondrion-Directed Nanoparticles Loaded with a Natural Compound and a microRNA for Promoting Cancer Cell Death via the Modulation of Tumor Metabolism and Mitochondrial Dynamics
|Pharmaceutics|2020|19